<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="36903">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02015221</url>
  </required_header>
  <id_info>
    <org_study_id>ACTitouch EOU</org_study_id>
    <nct_id>NCT02015221</nct_id>
  </id_info>
  <brief_title>Evaluation of a Dual Action Pneumatic Compression Device: Patient Ease of Use and Comfort</brief_title>
  <official_title>Evaluation of a Dual Action Pneumatic Compression Device: Patient Ease of Use and Comfort</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tactile Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tactile Medical</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the ease of use and comfort of the ACTitouch dual
      action pneumatic compression device in patients with unilateral or bilateral chronic venous
      insufficiency (CVI) with or without venous leg ulcers, as compared to standard compression.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects will be randomized to receive either the ACTitouch system or standard compression
      garments, and will respond to symptom surveys and quality of life surveys to assess comfort
      and ease of use of each. These will be conducted at Baseline, at Day 15 and Day 30.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">August 2014</completion_date>
  <primary_completion_date type="Anticipated">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label</study_design>
  <primary_outcome>
    <measure>Ease of use and comfort for subjects using the ACTitouch system.</measure>
    <time_frame>30 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>Questionnaire, analysis</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Chronic Venous Insufficiency</condition>
  <arm_group>
    <arm_group_label>ACTitouch</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ACTitouch in sustained gradient compression mode during all waking hours (at least 10 hours per day) and intermittent pneumatic compression mode for 2 hours each day.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Compression Garments</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard Compression Garments of compression levels 30mmHg to 40mmHg during all waking hours each day.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dual Action Pneumatic Compression Device</intervention_name>
    <description>A novel dual action pneumatic compression device that provides both sustained compression while ambulatory, and intermittent pneumatic compression when connected to an AC outlet.</description>
    <arm_group_label>ACTitouch</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Standard Compression Garments</intervention_name>
    <description>Compression stockings with a 30-40mmHg level of compression.</description>
    <arm_group_label>Standard Compression Garments</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of unilateral or bilateral CVI with or without leg ulcers

          -  Documented history of low adherence to compression garment therapy

          -  CEAP classification C3-C6

          -  Leg circumferences within the following ranges: Ankle 12-44cm, calf 22-6m, below the
             knee 22-68cm

        Exclusion Criteria:

          -  History of skin sensitivity to any of the components of ACTitouch or compression
             garments

          -  History of acute (deep vein thrombosis) DVT or (pulmonary embolism) PE within the
             last 3 months

          -  Ankle Brachial Index (ABI) &lt; 0.8

          -  Acute thrombophlebitis

          -  History of pulmonary edema or decompensated congestive heart failure

          -  Currently has an active infection of the skin such as cellulitis requiring
             antibiotics

          -  Poorly controlled diabetes with an HbA1c value of &gt;10%

          -  Exhibits any condition which, according to the PI, justifies the subjects exclusion
             from the study, such as a medical condition where an increase in venous or lymphatic
             return is undesirable.

          -  Subjects with open ulcers must be le to follow their care regimen for ulcer healing
             concurrently with the assigned study regimen.

          -  Participating in another clinical trial

          -  Changes to medications that affect edema within the last 30 days

          -  Currently pregnant or trying to become pregnant
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fedor Lurie, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Associate Director, Jobst Vascular Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Fedor Lurie, MD, PhD</last_name>
    <phone>419-291-2088</phone>
    <email>fedor.lurie@promedica.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Associated Foot and Ankle Specialists, LLC</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85015</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Arthur Tallis, DPM</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Empire Orthopedic Center</name>
      <address>
        <city>Colton</city>
        <state>California</state>
        <zip>92324</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Jason Chiriano, DO, FACS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California, San Diego</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92093</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Matthew A Allison, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>VA Loma Linda Healthcare System</name>
      <address>
        <city>Loma Linda</city>
        <state>California</state>
        <zip>92357</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Christian Bianchi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Park Nicollet Heart and Vascular Center</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55426</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Matthew M Melin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stony Brook Vein Center</name>
      <address>
        <city>Stony Brook</city>
        <state>New York</state>
        <zip>11794-8191</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Antonios P Gasparis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospitals Case Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106-1261</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Teresa Carman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ohio Health System</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43214</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Raghu Kolluri, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jobst Vascular Institute</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Anthony Comerota, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Greenville Hospital System</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29615</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Marcus Stanbro, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 13, 2014</lastchanged_date>
  <firstreceived_date>December 2, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>chronic venous insufficiency</keyword>
  <keyword>venous leg ulcers</keyword>
  <keyword>pneumatic compression</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Venous Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
